ACHV

Conviction 80HealthcareScan · Thu, Sep 24, 2026

Achieve Life Sciences, Inc. (ACHV) closed at $7.83 (+0.00%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 53, RS Rating 98, -8.2% from its 52-week high, +57.6% year to date. Sector: Healthcare · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES.

ACHV$7.83+0.00%

ResistanceSupportVol 14Insider sell

Vol MA14 1.83M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

ACHIEVE LIFE SCIENCES, INC.IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.achievelifesciences.com ↗

Price7.83

Change+0.00%

Gap-0.51%

Rel volume0.91×

Avg volume1.65M

Avg $ vol12.85M

SMA 207.86

SMA 507.27

SMA 2005.35

Price vs 50+7.70%

Price vs 200+46.33%

MA stackbullish

50/200 cross—

Supertrenddown · 8.35

RSI (14)53

MACD hist-0.02

MACD cross—

Stoch %K / %D53 / 57

ADX (14)28

+DI / −DI25 / 18

RSI divergenceBearish

MACD divergenceBearish

ATR %5.23%

ADR %4.85%

52w high8.53

52w low2.65

From 52w high-8.21%

Above 52w low+195.47%

New 52w highNo

SqueezeOff

Bollinger width20.94%

%B0.48

Donchian pos50.31%

Donchian high8.64

Donchian low7.01

AVWAP (52w high)7.76

vs AVWAP high+0.89%

AVWAP (52w low)5.96

vs AVWAP low+31.36%

OBV trendFlat

Chaikin MF (20)-0.16

Today vs 20d0.91×

Avg vol (14d)1.83M

Avg vol (20d)1.65M

Avg $ vol (20d)12.85M

Market cap805.73M

RS Rating98 / 99

RS 3m (vs SPY)+32.88%

RS 6m (vs SPY)+160.84%

RS line new highNo

Trend template8/8

Technical rank82.8

1 week-1.01%

1 month-4.16%

3 months+37.37%

6 months+177.66%

1 year+157.57%

YTD+57.55%

P/E-14.74

P/B-54.90

P/S—

P/FCF-16.29

EPS-1.25

Div yield—

ROE372.36%

ROA-28.70%

Debt/Eq—

Current0.95

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-37.21%

Price target14.17

Target upside80.97%

Analyst ratingBuy

Institutional82.80%

Ent. value757.77M

Revenue—

Net income-74.77M

Gross profit—

Free cash flow-49.47M

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNasdaq

Shares out102.66M

Employees28

ListedThu, Oct 12, 1995

Free float39.1M

Float %73.5%

Short interest16.45M

Days to cover12.2d

Short volume59.5%

Squeeze score78 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.28 vs −$0.18

Last surprise-55.6% miss

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank82.8 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.63

Support6.76

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACHV

All disclosures →

No recent disclosed trades by Congress in ACHV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACHV · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
Stewart Richard Alistair Director · Common Stock · 2026-08-19	Sell	20.63K	$175K	2026-08-19	2026-08-21
Waldman Reid Alexander Director · Stock Option (right to buy) · 2026-05-29	Grant	47.25K	$0	2026-05-29	2026-06-02
Farrow Jeffrey S Director · Stock Option (right to buy) · 2026-05-29	Grant	47.25K	$0	2026-05-29	2026-06-02
Martin Christopher Nathan Director · Stock Option (right to buy) · 2026-05-11	Grant	47.25K	$0	2026-05-11	2026-05-13
Goldberg Andrew D. CEO and President · Performance Restricted Stock Unit (PRSU) · 2026-04-18	Grant	11.71M	$0	2026-04-18	2026-04-21
Goldberg Andrew D. CEO and President · Restricted Stock Unit (RSU) · 2026-04-18	Grant	1.8M	$0	2026-04-18	2026-04-21
Goldberg Andrew D. CEO and President · Stock Option (right to buy) · 2026-04-18	Grant	3.6M	$0	2026-04-18	2026-04-21

SEC filings

EDGAR filings in ACHV · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.